Skip to main content
SpringerLink
Log in

Nephrologische Erkrankungen

  • Chapter
Morbus Bechterew

  • 1536 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adhiyaman V, Asghar M, Oke A, White AD, Shah IU (2001) Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. JR Soc Med 94:512–514

    Google Scholar 

  • Ahmed A (2002) Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc 50:1297–1300

    Article  PubMed  Google Scholar 

  • Bennett WM, Henrich WL, Stoff JS (1996) The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations Am J Kidney Dis 28,Suppl.1:S56–62

    Google Scholar 

  • Berglund K, Keller C, Thysell H (1987) Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease. Ann Rheum Dis 46:757–762

    PubMed  Google Scholar 

  • Bruneau C, Villiaumey J, Avouac B, Martigny J, Laurent J, Pichot A, Belghiti D, Lagrue G (1986) Seronegative spondyloarthropathies and IgA glomerulonephritis: a report of four cases and a review or the literature. Semin Arthritis Rheum 15:179–184

    Article  PubMed  Google Scholar 

  • Buxbaum JN (2004) The systematic amyloidoses. Curr Opin Rheumatol 16:67–75

    PubMed  Google Scholar 

  • Chen A, Ho YS, Tu YC, Shieh SD, Hung HW, Chou CT (1988) Immunoglobulin A nephropathy and ankylosing spondylitis. Report of two patients in Taiwan and review of the literature. Nephron 49:313–318

    PubMed  Google Scholar 

  • Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Eng J Med 310:563–572

    Google Scholar 

  • D’Amico GD, Ragni A, Torpia R (1989) Factors of progression in IgA mesangial nephropathy. Contrib Nephrol 75:76–81

    PubMed  Google Scholar 

  • de la Iglesia Martinez F, Grana Gil J, Gomez Veiga F, Rodriguez Garcia J, Gomez Rodriguez N, Atanes Sandoval A (1992) The association of idiopathic retroperitoneal fibrosis and ankylosing spondylitis. J Rheumatol 19:1147–1149

    PubMed  Google Scholar 

  • Donadio JV, Grande JP (2002) IgA nephropathy. N Eng J Med 347:738–748

    Article  Google Scholar 

  • Escalante A, Weaver WJ, Beardmore TD (1995) An estimate of the prevalence of reactive systemic amyloidosis in ankylosing spondylitis. J Rheum 22:2192–2193

    PubMed  Google Scholar 

  • Fiehn C, Andrassy K (2004) Case number 29: hitting three with one strike: rapid improvement of psoriatic arthritis, psoriatic erythroderma, and secondary renal amyloidosis by treatment with infliximab (Remicade). Ann Rheum Dis 63:232

    Article  PubMed  Google Scholar 

  • FitzGerald GA, Patrono C (2001) Drug therapy: The coxibs, selective inhibitors of cyclooxy-genase-2. N Eng J Med 345:433–442

    Google Scholar 

  • Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, Zack MM, Nyrén O (2001) Acetaminophen, aspirin, and chronic renal failure. N Eng J Med 345:1801–1808

    Article  Google Scholar 

  • Galla JH (1995) Perspectives in clinical nephrology: IgA nephropathy. Kidney Int 47:377–378

    PubMed  Google Scholar 

  • Gansevoort RT, Sluiter WJ, Hemmelder MH, De Zeeuw D, De Jong PE (1995) Antiproteinuric effect of blood pressure lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963–1974

    PubMed  Google Scholar 

  • Gratacos J, Orellana C, Sanmarti R, Sole M, Collado A, Gomez-Casanovas E, de Dios Canete J, Munoz-Gomez J (1997) Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheum 24:912–915

    PubMed  Google Scholar 

  • Guo X, Nzerue C (2002) How to prevent, recognize, and treat drug-induced nephrotoxicity. Cleve Clin J Med 69:289–297

    PubMed  Google Scholar 

  • Henao J, Hisamuddin I, Nzerue CM, Vasandani G, Hewan-Lowe K (2002) Celecoxib-induced acute interstitial nephritis. Am J Kidney Dis 39:1313–1317

    PubMed  Google Scholar 

  • Henry D, Page J, Whyte I (1997) Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case — control study. Br J Pharmacol 44:85–90

    Article  Google Scholar 

  • Jones DW, Mansell MA, Samuell CT, Isenberg DA (1987) Renal abnormalities in ankylosing spondylitis. Br J Rheum 26:341–345

    Google Scholar 

  • Kovacsovics-Bankowski M, Zufferey P, So AKL, Gerster JC (2000) Secondary amyloidosis: a severe complication of ankylosing spondylitis. Two case-reports. Joint Bone Spine 67:129–133

    PubMed  Google Scholar 

  • Lehtinen K (1983) Seventy-six patients with ankylosing spondylitis seen after 30 years of disease. Scand J Rheum 12:5–11

    PubMed  Google Scholar 

  • Michel DM, Kelly CJ (1998) Acute interstitial nephritis. J Am Soc Nephrol 9:507–514

    Google Scholar 

  • Perazella MA, Eras J (2000) Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 35:937–940

    PubMed  Google Scholar 

  • Perneger TV, Whelton PK, Klag MF (1994) Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 331:1675–1679

    PubMed  Google Scholar 

  • Rocha JL, Fernandez-Alonso J (2001) Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. Lancet 357:1946–1947

    PubMed  Google Scholar 

  • Shu KH, Lian JD, Yang YF, Lu YS, Wang JY, Lan JL, Chou G (1986) Glomerulonephritis in ankylosing spondylitis. Clin Nephrol 25:169–174

    PubMed  Google Scholar 

  • Strobel ES, Fritschka E (1998) Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 17:524–530

    PubMed  Google Scholar 

  • Stürmer T, Elseviers MM, De Broe ME (2001) Nonsteroidal anti-inflammatory drugs and the kidney. Curr Opin Nephrol Hypertens 10:161–163

    PubMed  Google Scholar 

  • Vilar MJP, Cury SE, Ferraz MB, Sesso R, Atra E (1997) Renal abnormalities in ankylosing spondylitis. Scand J Rheum 26:19–23

    PubMed  Google Scholar 

Download references

Authors
  1. Annette Seiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sonderkrankenanstalt — Rehabilitationszentrum Bad Ischl-Lindau Pensionsversicherungsanstalt, Bad Ischl, Österreich

    Albrecht Felkenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag/Wien

About this chapter

Cite this chapter

Seiler, A. (2005). Nephrologische Erkrankungen. In: Felkenbach, A. (eds) Morbus Bechterew. Springer, Vienna. https://doi.org/10.1007/3-211-26646-1_16

Download citation

  • DOI: https://doi.org/10.1007/3-211-26646-1_16

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-00808-9

  • Online ISBN: 978-3-211-26646-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation